Cargando…
Pilot Trial on the Effect of 5-Aminolevulinic Acid on Glucose Tolerance in Patients with Maternally Inherited Diabetes and Deafness
INTRODUCTION: The amino acid 5-aminolevulinic acid (5-ALA) is the first heme biosynthetic precursor. The combination of 5-ALA with sodium ferrous citrate (SFC) enhances heme production, leading to increased adenosine triphosphate (ATP) production in mitochondria. We investigated whether administerin...
Autores principales: | Nakamura, Yuta, Haraguchi, Ai, Horie, Ichiro, Kawakami, Atsushi, Abiru, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943925/ https://www.ncbi.nlm.nih.gov/pubmed/36418716 http://dx.doi.org/10.1007/s13300-022-01335-8 |
Ejemplares similares
-
ODP158 A Pilot Trial on the Efficacy of 5-Aminolevulinic Acid on Glucose Tolerance in Patients with Maternally Inherited Diabetes and Deafness
por: Nakamura, Yuta, et al.
Publicado: (2022) -
A single-arm, open-label, intervention study to investigate the improvement of glucose tolerance after administration of the 5-aminolevulinic acid (5-ALA) in the patients with mitochondrial diabetes mellitus
por: Nakamura, Yuta, et al.
Publicado: (2021) -
Impact of glucagon response on early postprandial glucose excursions irrespective of residual β‐cell function in type 1 diabetes: A cross‐sectional study using a mixed meal tolerance test
por: Ito, Ayako, et al.
Publicado: (2021) -
Impaired early‐phase suppression of glucagon secretion after glucose load is associated with insulin requirement during pregnancy in gestational diabetes
por: Horie, Ichiro, et al.
Publicado: (2019) -
Sex differences in insulin and glucagon responses for glucose homeostasis in young healthy Japanese adults
por: Horie, Ichiro, et al.
Publicado: (2018)